Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C: A retrospective study

C. H. Lee, I. K. Wang, T. C. Chen, H. W. Chang, C. C. Yang, Y. S. Chien, C. S. Wu, T. T Y Chiou, M. S. Wu, P. H. Wang, Feng Rong Chuang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hepatitis C virus causes various extrahepatic immunologic abnormalities. Vascular access thrombosis (VAT) is a major cause of morbidity in chronic haemodialysis (HD) patients. Immunoglobulin-G anticardiolipin antibody (IgG-ACA) is strongly associated with venous and arterial thrombosis in patients with normal renal function. Previous investigations have reported the association of raised IgG-ACA titre recurrent with VAT in HD patient, and also few equivalent studies were reported the same in Taiwan. This study attempted to determine whether raised IgG-ACA titres are associated with increased risk of recurrent VAT in HD patients with chronic hepatitis C. This study enrolled 98 chronic hepatitis C patients undergoing HD. IgG-ACA titre and hepatitis C marker were measured for all subjects. Raised IgG-ACA titres were present in 29.6% (29/98) of patients. In both groups (raised and normal IgG-ACA), the type of shunt did not differ (p = 0.416). There was strong association between raised IgG-ACA titre and recurrent VAT (p = 0.0004). In predicting for more or one episodes of VAT using multiple logistic regression, synthetic graft (p <0.0001), raised IgG-ACA titre (p = 0.039), presence of hepatitis B (p = 0.004) and haemodialysis duration (p = 0.039) were significant factors. The prevalence of raised IgG-ACA titres was 39.6% among chronic hepatitis C with HD patients. There was strong association between raised IgG-ACA titre and recurrent VAT, and this finding may be the consequence of pathogenetic role of raised IgG-ACA titres on the development of VAT status in HD patients with chronic hepatitis C.

Original languageEnglish
Pages (from-to)1591-1595
Number of pages5
JournalInternational Journal of Clinical Practice
Volume60
Issue number12
DOIs
Publication statusPublished - Dec 2006
Externally publishedYes

Fingerprint

Anticardiolipin Antibodies
Chronic Hepatitis C
Blood Vessels
Renal Dialysis
Thrombosis
Retrospective Studies
Immunoglobulin G
Hepatitis C
Hepatitis B
Taiwan
Venous Thrombosis
Hepacivirus
Logistic Models

Keywords

  • Anticardiolipin antibody
  • Chronic hepatitis C
  • Haemodialysis
  • Vascular access thrombosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C : A retrospective study. / Lee, C. H.; Wang, I. K.; Chen, T. C.; Chang, H. W.; Yang, C. C.; Chien, Y. S.; Wu, C. S.; Chiou, T. T Y; Wu, M. S.; Wang, P. H.; Chuang, Feng Rong.

In: International Journal of Clinical Practice, Vol. 60, No. 12, 12.2006, p. 1591-1595.

Research output: Contribution to journalArticle

Lee, C. H. ; Wang, I. K. ; Chen, T. C. ; Chang, H. W. ; Yang, C. C. ; Chien, Y. S. ; Wu, C. S. ; Chiou, T. T Y ; Wu, M. S. ; Wang, P. H. ; Chuang, Feng Rong. / Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C : A retrospective study. In: International Journal of Clinical Practice. 2006 ; Vol. 60, No. 12. pp. 1591-1595.
@article{67c5087f03654b9b9e1ce71de9bb1d39,
title = "Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C: A retrospective study",
abstract = "Hepatitis C virus causes various extrahepatic immunologic abnormalities. Vascular access thrombosis (VAT) is a major cause of morbidity in chronic haemodialysis (HD) patients. Immunoglobulin-G anticardiolipin antibody (IgG-ACA) is strongly associated with venous and arterial thrombosis in patients with normal renal function. Previous investigations have reported the association of raised IgG-ACA titre recurrent with VAT in HD patient, and also few equivalent studies were reported the same in Taiwan. This study attempted to determine whether raised IgG-ACA titres are associated with increased risk of recurrent VAT in HD patients with chronic hepatitis C. This study enrolled 98 chronic hepatitis C patients undergoing HD. IgG-ACA titre and hepatitis C marker were measured for all subjects. Raised IgG-ACA titres were present in 29.6{\%} (29/98) of patients. In both groups (raised and normal IgG-ACA), the type of shunt did not differ (p = 0.416). There was strong association between raised IgG-ACA titre and recurrent VAT (p = 0.0004). In predicting for more or one episodes of VAT using multiple logistic regression, synthetic graft (p <0.0001), raised IgG-ACA titre (p = 0.039), presence of hepatitis B (p = 0.004) and haemodialysis duration (p = 0.039) were significant factors. The prevalence of raised IgG-ACA titres was 39.6{\%} among chronic hepatitis C with HD patients. There was strong association between raised IgG-ACA titre and recurrent VAT, and this finding may be the consequence of pathogenetic role of raised IgG-ACA titres on the development of VAT status in HD patients with chronic hepatitis C.",
keywords = "Anticardiolipin antibody, Chronic hepatitis C, Haemodialysis, Vascular access thrombosis",
author = "Lee, {C. H.} and Wang, {I. K.} and Chen, {T. C.} and Chang, {H. W.} and Yang, {C. C.} and Chien, {Y. S.} and Wu, {C. S.} and Chiou, {T. T Y} and Wu, {M. S.} and Wang, {P. H.} and Chuang, {Feng Rong}",
year = "2006",
month = "12",
doi = "10.1111/j.1742-1241.2006.00857.x",
language = "English",
volume = "60",
pages = "1591--1595",
journal = "International Journal of Clinical Practice",
issn = "1368-5031",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C

T2 - A retrospective study

AU - Lee, C. H.

AU - Wang, I. K.

AU - Chen, T. C.

AU - Chang, H. W.

AU - Yang, C. C.

AU - Chien, Y. S.

AU - Wu, C. S.

AU - Chiou, T. T Y

AU - Wu, M. S.

AU - Wang, P. H.

AU - Chuang, Feng Rong

PY - 2006/12

Y1 - 2006/12

N2 - Hepatitis C virus causes various extrahepatic immunologic abnormalities. Vascular access thrombosis (VAT) is a major cause of morbidity in chronic haemodialysis (HD) patients. Immunoglobulin-G anticardiolipin antibody (IgG-ACA) is strongly associated with venous and arterial thrombosis in patients with normal renal function. Previous investigations have reported the association of raised IgG-ACA titre recurrent with VAT in HD patient, and also few equivalent studies were reported the same in Taiwan. This study attempted to determine whether raised IgG-ACA titres are associated with increased risk of recurrent VAT in HD patients with chronic hepatitis C. This study enrolled 98 chronic hepatitis C patients undergoing HD. IgG-ACA titre and hepatitis C marker were measured for all subjects. Raised IgG-ACA titres were present in 29.6% (29/98) of patients. In both groups (raised and normal IgG-ACA), the type of shunt did not differ (p = 0.416). There was strong association between raised IgG-ACA titre and recurrent VAT (p = 0.0004). In predicting for more or one episodes of VAT using multiple logistic regression, synthetic graft (p <0.0001), raised IgG-ACA titre (p = 0.039), presence of hepatitis B (p = 0.004) and haemodialysis duration (p = 0.039) were significant factors. The prevalence of raised IgG-ACA titres was 39.6% among chronic hepatitis C with HD patients. There was strong association between raised IgG-ACA titre and recurrent VAT, and this finding may be the consequence of pathogenetic role of raised IgG-ACA titres on the development of VAT status in HD patients with chronic hepatitis C.

AB - Hepatitis C virus causes various extrahepatic immunologic abnormalities. Vascular access thrombosis (VAT) is a major cause of morbidity in chronic haemodialysis (HD) patients. Immunoglobulin-G anticardiolipin antibody (IgG-ACA) is strongly associated with venous and arterial thrombosis in patients with normal renal function. Previous investigations have reported the association of raised IgG-ACA titre recurrent with VAT in HD patient, and also few equivalent studies were reported the same in Taiwan. This study attempted to determine whether raised IgG-ACA titres are associated with increased risk of recurrent VAT in HD patients with chronic hepatitis C. This study enrolled 98 chronic hepatitis C patients undergoing HD. IgG-ACA titre and hepatitis C marker were measured for all subjects. Raised IgG-ACA titres were present in 29.6% (29/98) of patients. In both groups (raised and normal IgG-ACA), the type of shunt did not differ (p = 0.416). There was strong association between raised IgG-ACA titre and recurrent VAT (p = 0.0004). In predicting for more or one episodes of VAT using multiple logistic regression, synthetic graft (p <0.0001), raised IgG-ACA titre (p = 0.039), presence of hepatitis B (p = 0.004) and haemodialysis duration (p = 0.039) were significant factors. The prevalence of raised IgG-ACA titres was 39.6% among chronic hepatitis C with HD patients. There was strong association between raised IgG-ACA titre and recurrent VAT, and this finding may be the consequence of pathogenetic role of raised IgG-ACA titres on the development of VAT status in HD patients with chronic hepatitis C.

KW - Anticardiolipin antibody

KW - Chronic hepatitis C

KW - Haemodialysis

KW - Vascular access thrombosis

UR - http://www.scopus.com/inward/record.url?scp=33751003486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751003486&partnerID=8YFLogxK

U2 - 10.1111/j.1742-1241.2006.00857.x

DO - 10.1111/j.1742-1241.2006.00857.x

M3 - Article

C2 - 16704678

AN - SCOPUS:33751003486

VL - 60

SP - 1591

EP - 1595

JO - International Journal of Clinical Practice

JF - International Journal of Clinical Practice

SN - 1368-5031

IS - 12

ER -